Effect of Unani drug in obesity
Phase 2
- Conditions
- Health Condition 1: E669- Obesity, unspecified
- Registration Number
- CTRI/2022/04/041816
- Lead Sponsor
- Rajiv Gandhi university of health and science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients between the age group of 20â??60 years and all gender
Patients with Body Mass Index >= 25 to <= 29.9kg/m2(Indian Asian Criteria suggested by WHO)
Patients who will give consent and are able to do follow up
Exclusion Criteria
Patients below 20 and above 60 years
Patients having BMI < 25 and >29.9 kg/m2
Patient with hypothyroidism, systemic illness, psychiatric disorder malignancy etc.
Use of drugs or supplements known to significantly affect body weight within the past 3 months.
History of bariatric surgery or abdominal adhesion after surgery.
Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in physical parameters of the bodyTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Improvement in IWQOL-LITE CT Questionnaire & Decrease in Lipid LevelTimepoint: 45 days